Influence of erythrocyte oxygenation and intravascular ATP on resting and exercising skeletal muscle blood flow in humans with mitochondrial myopathy

Mitochondrion

Volumn 12, Issue 3, 2012, Pages 414-422

  Jeppesen, Tina D ^a,b   Vissing, John ^a,b   González Alonso, José ^b,c  

^a Neuromuscular Research Unit   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

ATP; Erythrocyte signaling; Mitochondrial myopathy

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; OXYGEN; OXYHEMOGLOBIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD OXYGENATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMIC EXERCISE; ERYTHROCYTE; EXERCISE; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; GENE MUTATION; HUMAN; HYPEROXIA; HYPOXIA; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE BLOOD FLOW; MUSCLE PERFUSION; OXYGENATION; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; BLOOD FLOW VELOCITY; DNA, MITOCHONDRIAL; ERYTHROCYTES; EXERCISE; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; POINT MUTATION; REST;

EID: 84861456298     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.11.003     Document Type: Article

References (44)

1. Abe K., Matsuo Y., Kadekawa J., Inoue S., Yanagihara T. Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by noninvasive tissue oximetry. Neurology 1997, 49:837-841.
2. Andersen P., Saltin B. Maximal perfusion of skeletal muscle in man. J. Physiol. 1985, 366:233-249.
3. Bank W., Chance B. An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry. Ann. Neurol. 1994, 36:830-837.
4. Bank W., Chance B. Diagnosis of defects in oxidative muscle metabolism by non-invasive tissue oximetry. Mol. Cell. Biochem. 1997, 174:7-10.
5. Beigi R., Kobatake E., Aizawa M., Dubyak G.R. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. 1999, 276:267-278.
6. Bergfeld G.R., Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res. 1992, 26:40-47.
7. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J. Anat. 1999, 194:335-342.
8. Carroll J., Raththagala M., Subasinghe W., Baguzis S., D'amico Oblak T., Root P., Spence D. An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP. Mol. Biosyst. 2006, 2:305-311.
9. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon R.O., Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2008, 9:1498-1505.
10. Despas F., Detis N., Dumonteil N., Labrunee M., Bellon B., Franchitto N., Galinier M., Senard J.M., Pathak A. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation. J. Hypertens. 2009, 27:1849-1854.
11. Di Giovanni S., Mirabella M., Papacci M., Odoardi F., Silvestri G., Servidei S. Apoptosis and ROS detoxification enzymes correlate with cytochrome c oxidase deficiency in mitochondrial encephalomyopathies. Mol. Cell. Neurosci. 2001, 17:696-705.
12. Ellsworth M.L., Forrester T., Ellis C.G., Dietrich H.H. The erythrocyte as a regulator of vascular tone. Am. J. Physiol. 1995, 269:2155-2161.
13. Ellsworth M.L., Ellis C.G., Goldman D., Stephenson A.H., Dietrich H.H., Sprague R.S. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 2009, 24:107-116.
14. Fujii T., Okuno T., Ito M., Hattori H., Mutoh K., Go T., Shirasaka Y., Shiraishi H., Iwasaki Y., Asato R. 123I-IMP SPECT findings in mitochondrial encephalomyopathies. Brain Dev. 1995, 17:89-94.
15. González-Alonso J. ATP: a double-edged signalling molecule regulating the flow of oxygen. J. Physiol. 2008, 586:4033-4034.
16. González-Alonso J., Olsen D.B., Saltin B. Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ. Res. 2002, 91:1046-1055.
17. González-Alonso J., Mortensen S.P., Dawson E.A., Secher N.H., Damsgaard R. Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of hemoglobin. J. Physiol. 2006, 572:295-305.
18. Gropen T.I., Prohovnik I., Tatemichi T.K., Hirano M. Cerebral hyperemia in MELAS. Stroke 1994, 25:1873-1876.
19. Haller R.G., Lewis S.F., Estabrook R.W., DiMauro S., Servidei S., Foster D.W. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J. Clin. Invest. 1989, 84:155-161.
20. 2 delivery mediated by haemoglobin oxygenation. Am. J. Physiol. 2001, 280:2833-2839.
21. Jensen T.D., Kazemi-Esfarjani P., Skomorowska E., Vissing J. A forearm exercise screening test for mitochondrial myopathy. Neurology 2002, 58:1533-1538.
22. Jeppesen T.D., Schwartz M., Olsen D.B., Vissing J. Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy. Ann. Neurol. 2003, 54:86-92.
23. Kalsi K.K., González-Alonso J. Temperature sensitive erythrocyte ATP release: a mechanism of enhancing human limb tissue blood flow. Circulation 2010, 122. Abstract A13005.
24. Kirby B.S., Voyles W.F., Carlson R.E., Dinenno F.A. Graded sympatholytic effect of exogenous ATP on postjunctional alpha-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle. J. Physiol. 2008, 586:4305-4316.
25. Matsukawa T., Mano T., Gotoh E., Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J. Clin. Invest. 1993, 92:25-28.
26. Mortensen S.P., González-Alonso J., Bune L.T., Saltin B., Pilegaard H., Hellsten Y. ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:1140-1148.
27. Nishioka J., Akita Y., Yatsuga S., Katayama K., Matsuishi T., Ishibashi M., Koga Y. Inappropriate intracranial hemodynamics in the natural course of MELAS. Brain Dev. 2008, 30:100-105.
28. Notarius C.F., Atchison D.J., Floras J.S. Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:969-976.
29. Olsen D.B., Langkilde A.R., Ørngreen M.C., Rostrup E., Schwartz M., Vissing J. Muscle structural changes in mitochondrial myopathy relate to genotype. J. Neurol. 2003, 250:1328-1334.
30. Ozawa T., Sahashi K., Nakase Y., Chance B. Extensive tissue oxygenation associated with mitochondrial DNA mutations. Biochem. Biophys. Res. Commun. 1995, 213:432-438.
31. Pawloski J.R., Hess D.T., Stamler J.S. Export by red blood cells of nitric oxide bioactivity. Nature 2001, 409:622-626.
32. Rädegran G. Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J. Appl. Physiol. 1997, 83:1383-1388.
33. Rosenmeier J.B., Hansen J., González-Alonso J. Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J. Physiol. 2004, 558:351-365.
34. Rosenmeier J.B., Yegutkin G.G., González-Alonso J. Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle. J. Physiol. 2008, 586:4993-5002.
35. Schwartz M., Vissing J. Paternal inheritance of mitochondrial DNA. N. Engl. J. Med. 2002, 347:576-580.
36. Sprague R.S., Ellsworth M.L., Stephenson A.H., Kleinhenz M.E., Lonigro A.J. Deformation-induced ATP release from red blood cells requires CFTR activity. Am. J. Physiol. 1998, 275:1726-1732.
37. Strehler B., McElroy W. Assay of Adenosine Triphosphate 1957, 871-873. NY: Academic, New York.
38. Sumi Y., Woehrle T., Chen Y., Yao Y., Li A., Junger W.G. Adrenergic receptor activation involves ATP release and feedback through purinergic receptors. Am. J. Physiol. Cell Physiol. 2010, 299:1118-1126.
39. Taivassalo T., Shoubridge E.A., Chen J., Kennaway N.G., DiMauro S., Arnold D.L., Haller R.G. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann. Neurol. 2001, 50:133-141.
40. Taivassalo T., Abbott A., Wyrick P., Haller R.G. Venous oxygen levels during aerobic forearm exercise: an index of impaired oxidative metabolism in mitochondrial myopathy. Ann. Neurol. 2002, 51:38-44.
41. Taivassalo T., Jensen T.D., Kennaway N., DiMauro S., Vissing J., Haller R.G. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain 2003, 126:413-423.
42. Vissing J., Galbo H., Haller R.G. Exercise fuel mobilization in mitochondrial myopathy: a metabolic dilemma. Ann. Neurol. 1996, 40:655-662.
43. Vissing J., Salamon M.B., Arlien-Søborg P., Nørby S., Manta P., DiMauro S., Schmalbruch H. A new mitochondrial tRNA(Met) gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 1998, 50:1875-1878.
44. Zhang Z.Q., Niu S.T., Liang X.H., Jian F., Wang Y. Vascular involvement in the pathogenesis of mitochondrial encephalomyopathies. Neurol. Res. 2010, 32:403-408.